We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+15.53%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
AUM
$87.4M
AUM Growth
+$15.7M
Cap. Flow
+$13.1M
Cap. Flow %
14.97%
Top 10 Hldgs %
42.53%
Holding
870
New
303
Increased
61
Reduced
108
Closed
254

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.89M
2
VMW
VMware, Inc
VMW
+$1.8M
3
VIVO
Meridian Bioscience Inc
VIVO
+$1.69M
4
CMBT
CMB.TECH NV
CMBT
+$1.68M
5
LI icon
Li Auto
LI
+$1.62M

Sector Composition

Rank Sector Weight
1 Healthcare 23.03%
2 Technology 17.85%
3 Industrials 13.58%
4 Communication Services 8.63%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRTX
776
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-25
Closed -$1K
FTCH
777
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-310
Closed -$1K
CZOO
778
DELISTED
Cazoo Group Ltd
CZOO
0
JHAA
779
DELISTED
Nuveen Corporate Income 2023 Target Term Fund
JHAA
$0 ﹤0.01%
+50
New +$460
PRPC
780
DELISTED
CC Neuberger Principal Holdings III
PRPC
-100
Closed -$1K
AAC.U
781
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
-1,800
Closed -$18K
CANO
782
DELISTED
Cano Health, Inc.
CANO
$0 ﹤0.01%
1
-275
-100% -$37.3K
CCV.WS
783
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$0 ﹤0.01%
4,750
CCV
784
DELISTED
Churchill Capital Corp V
CCV
-900
Closed -$8K
ADERU
785
DELISTED
26 Capital Acquisition Corp Unit
ADERU
-100
Closed
HARP
786
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
-200
Closed -$1K
IDEX
787
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$0 ﹤0.01%
4
GFX
788
DELISTED
Golden Falcon Acquisition Corp.
GFX
-102
Closed -$1K
IRNT
789
DELISTED
IronNet, Inc.
IRNT
-7,464
Closed -$1K
SUMO
790
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-1
Closed
SI
791
PUT
DELISTED
Silvergate Capital Corporation
SI
-120
Closed -$2K
FRC.PRH
792
DELISTED
First Republic Bank
FRC.PRH
$0 ﹤0.01%
+135
New +$2.47K
HZON
793
DELISTED
Horizon Acquisition Corporation II
HZON
$0 ﹤0.01%
+300
New +$3.01K
HZON.WS
794
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
-300
Closed
TIG
795
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
-5,554
Closed -$33K
BSGAR
796
DELISTED
Blue Safari Group Acquisition Corp. Right
BSGAR
$0 ﹤0.01%
900
DMYS.U
797
DELISTED
dMY Technology Group, Inc. VI Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
DMYS.U
-300
Closed -$3K
SJR
798
DELISTED
Shaw Communications Inc.
SJR
-12,000
Closed -$345K
RAM
799
DELISTED
Aries I Acquisition Corporation Class A Ordinary Share
RAM
-2,000
Closed -$20K
SGFY
800
DELISTED
Signify Health, Inc.
SGFY
-7,000
Closed -$200K

Similar funds

FNY Investment Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, FNY Investment Advisers held 870 positions worth $87.4M, up 22% from $71.6M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

FNY Investment Advisers deployed $13.1M of net new capital in Q1 2023, opening 303 new positions and adding to 61 existing holdings. Its largest new stake was Oak Street Health, Inc.: 211,646 shares worth $8.19M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 5.3% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Amazon, an estimated $1.89M trimmed.

  • FNY Investment Advisers's largest Q1 2023 buy was Oak Street Health, Inc.: 211,646 shares worth $8.19M.
  • FNY Investment Advisers added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $6.29M increase.
  • FNY Investment Advisers's biggest Q1 2023 reduction was Amazon, cutting an estimated $1.89M.
  • FNY Investment Advisers fully exited Meridian Bioscience Inc in Q1 2023, selling an estimated $1.69M.
  • FNY Investment Advisers's ten largest holdings make up 43% of its $87.4M portfolio in Q1 2023.
  • FNY Investment Advisers opened 303 new positions and closed 254 in Q1 2023.
  • FNY Investment Advisers's portfolio value rose 22% quarter-over-quarter to $87.4M.

Based on FNY Investment Advisers's 13F filing for Q1 2023, filed 12 Apr 2023.